as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹26,955.0
Change
+95.0 (0.35%)
Open
₹26,860.0
Prev. Close
₹26,860.0
Day High
₹27,095.0
Day Low
₹26,860.0
Volume Analysis
Traded
2,263
Delivered
1,096
Delivery %
48.43%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹27,315.0 | ₹27,205.0 | ₹27,080.0 | ₹26,970.0 | ₹26,845.0 | ₹26,735.0 | ₹26,610.0 |
| Fibonacci | ₹27,205.0 | ₹27,115.23 | ₹27,059.77 | ₹26,970.0 | ₹26,880.23 | ₹26,824.77 | ₹26,735.0 |
| Camarilla | ₹27,019.63 | ₹26,998.08 | ₹26,976.54 | ₹26,970.0 | ₹26,933.46 | ₹26,911.92 | ₹26,890.38 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-5.37%
1 Week
-0.02%
1 Month
+2.98%
3 Months
+5.96%
6 Months
+1.76%
1 Year
-9.36%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.
TopFund Analysis
Abbott India Limited holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 65/100. The strongest factor is Risk & Volatility (95/100), while Institutional Ownership (36/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
65/100 — GoodData confidence: 60/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Corporate Governance
Institutional Ownership
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Company Secretary and Compliance Officer Sangeeta Shetty resigns, effective October 28, 2026.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 16.01% | 16.09% | 15.92% | 16.01% | 15.86% | 15.85% | 15.94% | 15.67% | 15.74% | 15.83% | 15.81% | 15.85% |
| Promoters | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% |
| FII | 0.19% | 0.18% | 0.18% | 0.18% | 0.17% | 0.17% | 0.16% | 0.16% | 0.16% | 0.19% | 0.27% | 0.38% |
| DII | 8.83% | 8.73% | 8.91% | 8.81% | 9.0% | 9.01% | 8.91% | 9.18% | 9.11% | 9.0% | 8.93% | 8.77% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Abbott India Limited (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 444,405 | 35.2 | 5.32 | 16.0% |
| Divi S Laboratories Ltd | 255,487 | 85.8 | 15.25 | 16.5% |
| Torrent Pharmaceuticals L | 189,746 | 85.0 | 20.11 | 27.4% |
| Apollo Hospitals Enter. L | 128,055 | 60.9 | 13.51 | 21.2% |
| Zydus Lifesciences Ltd | 115,890 | 23.8 | 4.32 | 21.2% |
| Cipla Ltd | 111,060 | 31.0 | 3.23 | 11.6% |
Which Mutual Funds Hold Abbott India Limited?
Frequently Asked Questions about Abbott India Limited
Abbott India Limited (ABBOTINDIA) closed at ₹26,955.0 on NSE on 25 September 2026, up 95.0 (0.35%) from the previous close.
Abbott India Limited trades on the NSE (National Stock Exchange of India) under the symbol ABBOTINDIA.
Abbott India Limited has a TopFund Quality Score of 65/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Abbott India Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.